McMurray JJV, Solomon SD, Lock JP, Massaro JM, et al. Meta-analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozin. Diabetes Obes Metab 2023 Dec 27. doi: 10.1111/dom.15394.
PMID: 38151752